Navigation Links
New data from NIH lab confirms protocol to reverse type 1 diabetes in mice

e of at least some of the regenerated islet cell and hastened the restoration of blood sugar levels.

The direct contribution of spleen cells to islet recovery, first described in the 2003 study, is confirmed in the current work. NIH researchers used cell lineage tracking in the form of Y-chromosomal fluorescence in situ hybridization (FISH), in combination with insulin staining, to follow the fate of male spleen cells transplanted into female recipients. The female mice that received male donor cells consistently showed Y-chromosome-positive insulin-producing islet cells, indicating that the introduced spleen cells contribute to islet recovery. The current study also showed that the degree of spleen cell contribution is influenced by mouse age at the start of treatment. Spleen cells appear to contribute to islet recovery more in mice who are older and with more advanced diabetes compared with younger mice with less advanced diabetes, in which regeneration of remaining islets may be the dominant mechanism.

Source-Eurekalert
'"/>




Page: 1 2

Related medicine news :

1. SARS research confirms link to animals
2. Irritable bowel syndrome associated with food intake, confirms blood test
3. Skin tests confirms cancer
4. Roche confirms Tamiflu production talks in US
5. Good news: there is no threat of bird flu confirms US
6. AIIMS medical Superintendent confirms that salary release has not been permitted
7. Creams may not reverse aging
8. Researchers reversed the process of memory loss
9. Vitamin C reverses pre eclampsia
10. Vitamin E, the latest warrior against diabetes
11. No vaccination - diabetes link
Post Your Comments:
(Date:10/8/2008)...n & Laser Center is well established as a tech...w York City. The facility is living up to its repu... skin resurfacing treatments to receive FDA approv..., New York, NY (PRWEB) Oct...atment industry is in the midst of an unprecedente...
(Date:10/7/2008)...elated Questions for Tonight,s,Presidential Debate...D, the leading source of,health information, today...ndidates, proposed health care policies, located a...candidates, stance on health insurance, medical an...c health issues., The in-depth coverage is just o...
(Date:10/7/2008)...Newswire-USNewswire/ -- IPRO, one of the,nation,s ...ations, has,created a Limited Liability Company (L...t oversight and consulting contracts with managed ...l (http://www.logiqual.com ), is now,officially i...w.newscom.com/cgi-bin/prnh/20081007/DC37283LOGO-a ...
(Date:10/7/2008)...-USNewswire/ -- As the presidential,candidates com...ate, Jean,Berg, a nursing assistant and member of ...waiting to ask John McCain why he wants to tax hea...o afford coverage., Berg has been a nursing assis...are., "It,s the single biggest economic factor in...
Breaking Medicine News(10 mins):Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:IPRO Spins Off Managed Care Review Affiliate 2Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2
...eading player in the Indian drug industry, has rec...Authority (FDA) for three// of its abbreviated new...d will be launching this product in the US through...potex, the Chennai-based company said in a release...
...eople suffering from osteoporosis are not told abo...cording to the research by the University of Weste...alians being affected by osteoporosis, the problem...ly. Dr Charles Inderjeeth from the School of Popu...
...rimination against HIV/AIDS victims will be tabled...or approval.// In the light of the XVI Internatio...i Ramadoss said, "it took a little time, because w...d elaborate discussions with the stakeholders. Hop...
...ed yesterday that a Walkers crisps advertising cam...ntent.// According to the industry watchdog a pro...salt in its crisps to "7% of your guideline daily ...act that the reduction did not apply to all Walker...
Other Medicine News:Health News:Negligence in Osteoporosis treatment 2Health News:Legislation to Prevent Discrimination against HIV/AIDS Victims 2
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A...examining embryonic stem cell self-renewal,report...lastim (recombinant,human serum albumin) was an ef...cell culture., The article entitled, "The ground ...sed that researchers used Cellastim as a recombina...
(Date:10/7/2008)... CAMBRIDGE, Mass., Oct. 7 /- Tali... data on several of the Company,s pipeline,candida...ement Workshop in,Basel, Switzerland. The data hig...l models of complement-mediated diseases., "These...vitro studies,presented at the conference, reveal ...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long-...n,s disease patients presented at American College.../- Data from two studies,pr...f Gastroenterology,(ACG) Annual Meeting demonstrat...EGylated anti-TNF alpha (Tumor Necrosis Factor alp...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- A...today that a poster entitled "RDEA119, a Potent,an...in Dextran Sulfate,Sodium (DSS) -- induced Chronic...ollege of Gastroenterology (ACG) 2008 Annual Meeti... data from a preclinical study of,RDEA119, the Com...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4The story of Max Perutz a pioneering biologist with a remarkable passion for life 2832 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
...ontinuous low-flow nebulizer performance. Patented...allows for optimal medication and Heliox delivery ...vere asthma, COPD and pneumonia in both routine an... mouth and T-piece to deliver high-output, low-flo...
... diverse medical products for more than 58 years. ...anding reputation for innovation, quality and cust...ecognized brands include the Labtron® line of ... products, Bristoline® microscopes, HealthTeam...
...contains everything the health care professional n...ickly and efficiently: 7 nebulizers, T-piece and m...yringe and needle., ,Shipped 5 kits per case., ,...ed Use: AsthmaKit is a procedural kit providing th...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only
Medicine Products: